Symlin and Lantus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Symlin (pramlintide acetate) and Lantus (insulin glargine recombinant). Common drug interactions include hypoglycaemia among females and blood glucose increased among males.
The phase IV clinical study analyzes what interactions people have when they take Symlin and Lantus. It is created by eHealthMe based on reports of 1,206 people who take the same drugs from the FDA, and is updated regularly.
What is Symlin?
Symlin has active ingredients of pramlintide acetate. It is often used in diabetes. eHealthMe is studying from 3,359 Symlin users. Check the latest studies of Symlin.
What is Lantus?
Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
1,206 people who take Symlin and Lantus together, and have interactions are studied.
What are the common drug interactions of Symlin and Lantus, by gender? *
What are the common drug interactions of Symlin and Lantus, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Symlin and Lantus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Symlin and Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Symlin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Symlin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pramlintide acetate and insulin glargine recombinant (the active ingredients of Symlin and Lantus, respectively), and Symlin and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zyprexa and Depakote Er - now
- Could Tamoxifen Citrate cause Urinary Retention? - 2 seconds ago
- Colonic Stenosis and drugs of ingredients of natalizumab - 3 seconds ago
- Alpha Haemolytic Streptococcal Infection and drugs of ingredients of nifedipine - 3 seconds ago
- Deep Venous Thrombosis and drugs of ingredients of bacillus coagulans - 3 seconds ago
- Drug interactions of Gravol and Gliclazide - 3 seconds ago
- Could Kisqali cause Bone Disorder? - 4 seconds ago
- Could Lyrica cause Rickets? - 5 seconds ago
- Could Nifedipine cause Chills? - 5 seconds ago
- Dysgraphia and drugs of ingredients of sucralfate - 10 seconds ago